Paratek Pharmaceuticals Inc
F:N4CN
Dividends
Dividend Yield
Paratek Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Paratek Pharmaceuticals Inc
Payout Ratio
Paratek Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for N4CN is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
N4CN Price
Paratek Pharmaceuticals Inc
| Average Annual Return | -44% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -87% |
| Market Capitalization | 115.9m EUR |
| Shares Outstanding | 57 282 239 |
| Percentage of Shares Shorted |
N/A
|
N4CN Return Decomposition
Main factors of price return
Stock Splits
N4CN's latest stock split occurred on Oct 31, 2014
The company executed a 1-for-12 stock split, meaning that for every 12 shares held, investors received 1 new share.
Before the split, N4CN traded at 1.273 per share. Afterward, the share price was about 14.85.
The adjusted shares began trading on Oct 31, 2014. This was the only stock split in N4CN's history.